Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.

Authors:
Gemechu Tadesse
Gemechu Tadesse
Ethiopian Public Health Institute
Solomon Mequanente Abay
Solomon Mequanente Abay
School of Pharmacy
Chapel Hill | United States
Tadesse Kebede
Tadesse Kebede
Addis Ababa University

BMC Res Notes 2019 Apr 5;12(1):211. Epub 2019 Apr 5.

Department of Microbiology Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Objective: Preschool age children (PSAC) are excluded from community based praziquantel treatment programs mainly due to paucity of evidence on the magnitude of schistosomiasis, efficacy and safety of this treatment in PSAC. The aim of this study is to assess Schistosoma mansoni infection rate and evaluate response to praziquantel in PSAC. A facility based longitudinal study was employed from April to June 2016 at Erer Health Center, Eastern Ethiopia. Stool sample was examined for schistosomiasis in 236 PSAC and repeated after 4 weeks post-treatment in positive individuals. Treatment outcomes were recorded and interpreted.

Results: Out of the 236 study participants, 59 (25%) were infected with S. mansoni. Praziquantel treatment (40 mg/kg) resulted in 96.4% cure rate and 99.4% egg reduction rate. Children of 3-5 year old were significantly affected with S. mansoni infection. Nausea and fatigue were common mild adverse events within 4 h of treatment however moderate and severe adverse events and allergic reactions were not observed. In conclusion, praziquantel at 40 mg/kg, the dose utilized in standard care for school age children, is tolerable and efficacious in the treatment of S. mansoni infection in PSAC, which calls for the healthcare system to provide appropriate service for this population.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-019-4246-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451229PMC
April 2019
2 Reads

Publication Analysis

Top Keywords

mansoni infection
16
age children
12
health center
8
praziquantel treatment
8
erer health
8
adverse events
8
preschool age
8
schistosoma mansoni
8
treatment
6
psac
5
praziquantel
5
psac repeated
4
post-treatment positive
4
repeated 4 weeks
4
standard care
4
4 weeks post-treatment
4
treatment outcomes
4
outcomes recorded
4
recorded interpretedresults
4
interpretedresults 236
4

References

(Supplied by CrossRef)
Article in J Parasitol Res
L Worku et al.
J Parasitol Res 2014
Article in Parasitol
A Fenwick et al.
Parasitol 2009
Article in Expert Opin Pharmacother
J Utzinger et al.
Expert Opin Pharmacother 2004
Article in Infect Dis Poverty
R Bergquist et al.
Infect Dis Poverty 2017
Article in PLoS Negl Trop Dis
JT Coulibaly et al.
PLoS Negl Trop Dis 2012
Article in Am J Trop Med Hyg
KY Won et al.
Am J Trop Med Hyg 2017
Article in Parasitology
U Ekpo et al.
Parasitology 2012
Article in BMC Public Health
A Alemu et al.
BMC Public Health 2016

World Health Organization et al.
2015

World Health Organization et al.
2006

JT Coulibaly et al.
2013

Similar Publications